BIOPHARM FORWARD ApS: Financial statements 2016
CVR: 32438784
Source: annual report 2016, Danish Business Authority
26/08/2015 – 25/08/2016
BIOPHARM FORWARD ApS (CVR 32438784) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -1,171 and a net result of DKK -1,171 compared with DKK -1,772 the year before. Equity in the 2016 report amounted to DKK -26,498.
- Gross Profit
- DKK -1,171
- Profit/Loss
- DKK -1,171
- Equity
- DKK -26,498
- Total Assets
- DKK 797
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -1 t. | -1 t. | -26 t. | - |
| 2015 | - | -2 t. | -2 t. | -25 t. | - |
| 2014 | - | -2 t. | -2 t. | -24 t. | - |
| 2013 | - | -2 t. | -2 t. | -21 t. | - |
| 2012 | - | -11 t. | -47 t. | -19 t. | - |
Official annual report
Find more companies like BIOPHARM FORWARD ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
BIOPHARM FORWARD ApS has published its annual report for 2015. Gross profit came to DKK -1,776, and the net result was DKK -1,772.
About BIOPHARM FORWARD ApS
BIOPHARM FORWARD ApS is a Danish company of the type Anpartsselskab based in Espergærde, founded in 2009. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Jonas Hink. The company is owned by Jonas Hink. The company has 0 employees (2011). In 2025, the company reported a gross profit of DKK 997,234 and a net result of DKK 243,660 compared with DKK 385,061 the year before. Equity in the 2025 report amounted to DKK 1,741,315.